1 year return (CAGR)
-36.73%
Leap Therapeutics Inc Exchange (NASDAQ, USD)
LPTX
-
+1.61 (+368.57%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
116.14M
Price/Sales
183.18
Ent value
112.33M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-0.42%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 0.60 |
| Daily high | 2.54 |
| Daily low | 0.58 |
| Daily Volume | 758M |
| 1y analyst estimate | 3.00 |
| Beta | 0.09 |
| EPS (TTM) | -1.57 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| LPTX | S&P500 | |
| Current price drop from All-time high | -97.95% | -0.58% |
| Highest price drop | -99.76% | -56.47% |
| Date of highest drop | 14 Aug 2025 | 9 Mar 2009 |
| Avg drop from high | -98.90% | -10.68% |
| Avg time to new high | - | 12 days |
| Max time to new high | 275 days | 1805 days |
News
No items found